NCT02973659View on ClinicalTrials.gov

The Use of Topical Oxybutynin 10% for Treating Primary Focal Hyperhidrosis-axillary, Palmar and Plantar.

NACompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

May 31, 2015

Primary Completion Date

August 31, 2016

Study Completion Date

October 31, 2016

Conditions

Hyperhidrosis

Interventions

DRUG

Oxybutynin

10% oxybutynin gel (one side) Vs placebo aqueous gel (other side) - 2/d application, 1 month

DRUG

Placebos

All Listed Sponsors

lead

Tel-Aviv Sourasky Medical Center

OTHER_GOV

NCT02973659 - The Use of Topical Oxybutynin 10% for Treating Primary Focal Hyperhidrosis-axillary, Palmar and Plantar. | Biotech Hunter | Biotech Hunter